Automated Insulin Delivery Personalization Using Back-Filled Basal Segments

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current insulin delivery systems for diabetes management impose a significant cognitive burden on patients and caregivers, requiring frequent manual adjustments and recalibration, and there is a lack of reliable, safe, and simple systems for automatic glycemic control.

Innovation Solution

A system and method that adjusts insulin delivery by determining available insulin delivery segments for a back-fill time, calculating cumulative insulin on board, and adjusting the baseline basal rate based on back-filled insulin delivery segments to achieve improved glycemic control.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If manual insulin dosage adjustments and recalibration are performed frequently, then glycemic control can be maintained, but cognitive burden on patients and caregivers increases significantly

Engineering Contradiction:
Improveglycemic controlVSAvoidcognitive burden
Core Design Contradiction:
ReliabilityVSEase of operation

Solution Approach 1:

The insulin delivery system automatically monitors glucose levels, calculates appropriate insulin dosages, and adjusts delivery parameters without requiring manual intervention. The system self-calibrates by monitoring glucose responses to insulin deliveries and automatically adjusts future dosages based on learned patterns, eliminating the need for frequent manual recalibration by patients or caregivers.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The system continuously monitors glucose levels and uses this feedback to automatically adjust insulin delivery. By tracking the relationship between insulin deliveries and subsequent glucose changes, the system learns individual patient responses and dynamically optimizes dosing parameters, maintaining reliable glycemic control while removing cognitive burden from users.

Inventive Principle:
Principle #23Feedback

2Ease of operation

If automated insulin delivery systems are implemented, then cognitive burden is reduced, but system complexity and reliability requirements increase

Engineering Contradiction:
Improvecognitive burdenVSAvoidautomatic control reliability
Core Design Contradiction:
Ease of operationVSReliability

Solution Approach 1:

The system performs self-calibration by automatically monitoring glucose responses to insulin deliveries and adjusting its control parameters accordingly. This self-learning capability reduces the need for manual intervention and external calibration, thereby improving reliability while maintaining automation.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The system pre-calculates insulin dosages based on predicted glucose trends and delivers insulin proactively before hyperglycemia occurs. By anticipating glucose excursions and pre-adjusting delivery parameters, the system maintains reliable control while operating automatically without requiring complex real-time decision-making.

Inventive Principle:
Principle #10Preliminary action

3Ease of operation

If simple and safe automated systems are developed, then ease of use improves, but achieving regulatory approval becomes more difficult

Engineering Contradiction:
ImprovesimplicityVSAvoidregulatory approval
Core Design Contradiction:
Ease of operationVSEase of manufacture

Solution Approach 1:

The system automatically adapts to individual patient needs through self-calibration, eliminating the need for complex manual programming and extensive customization. This simplicity in operation, combined with robust automated safety features and continuous monitoring, facilitates regulatory approval by demonstrating both ease of use and reliability.

Inventive Principle:
Principle #25Self-service

Data Source

PatentUS12551621B2System and method for adjusting insulin delivery
Publication Date: 2026.02.17 INSULET CORP
  • US12551621B2 patent drawing
  • US12551621B2 patent drawing
  • US12551621B2 patent drawing

AI summary

The embodiments described herein may relate to methods and systems for adjusting insulin delivery. Some methods and systems may be configured to adjust insulin delivery to personalize automated insulin delivery for a person with diabetes. Such personalization may include adjusting user specific dosage parameters in response to one or more back-filled time segments associated with a diurnal time block.